Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021;83(2):491-503.
doi: 10.3233/JAD-210425.

Cholinergic Deep Brain Stimulation for Memory and Cognitive Disorders

Affiliations
Review

Cholinergic Deep Brain Stimulation for Memory and Cognitive Disorders

Saravanan Subramaniam et al. J Alzheimers Dis. 2021.

Abstract

Memory and cognitive impairment as sequelae of neurodegeneration in Alzheimer's disease and age-related dementia are major health issues with increasing social and economic burden. Deep brain stimulation (DBS) has emerged as a potential treatment to slow or halt progression of the disease state. The selection of stimulation target is critical, and structures that have been targeted for memory and cognitive enhancement include the Papez circuit, structures projecting to the frontal lobe such as the ventral internal capsule, and the cholinergic forebrain. Recent human clinical and animal model results imply that DBS of the nucleus basalis of Meynert can induce a therapeutic modulation of neuronal activity. Benefits include enhanced activity across the cortical mantle, and potential for amelioration of neuropathological mechanisms associated with Alzheimer's disease. The choice of stimulation parameters is also critical. High-frequency, continuous stimulation is used for movement disorders as a way of inhibiting their output; however, no overexcitation has been hypothesized in Alzheimer's disease and lower stimulation frequency or intermittent patterns of stimulation (periods of stimulation interleaved with periods of no stimulation) are likely to be more effective for stimulation of the cholinergic forebrain. Efficacy and long-term tolerance in human patients remain open questions, though the cumulative experience gained by DBS for movement disorders provides assurance for the safety of the procedure.

Keywords: Acetylcholine; basal forebrain; prefrontal cortex; working memory.

PubMed Disclaimer

Conflict of interest statement

Authors’ disclosures available online (https://www.j-alz.com/manuscript-disclosures/21-0425r2).

Figures

Fig. 1
Fig. 1
A) Schematic illustration of monopolar (left) and bipolar stimulation (right). Arrows represent current flow from the stimulating electrode. B) Schematic illustration of monophasic and biphasic stimulation. Current amplitude is represented as a function of time.
Fig. 2
Fig. 2
A) Location of the nucleus basalis of Meynert (dotted ellipse) in the human brain. B) Targeted DBS for memory and cognitive enhancement. Schematic representation of bilateral deep brain stimulation of the nucleus basalis of Meynert. C) Target areas likely to undergo enhancement of activity after nucleus basalis stimulation include the prefrontal, parietal, and temporal association cortexes (shaded ellipses).
Fig. 3
Fig. 3
Schematic illustration of simultaneous recording and stimulation in a nonhuman primate performing a behavioral task.

Similar articles

Cited by

References

    1. Kogan M, McGuire M, Riley J (2019) Deep brain stimulation for Parkinson disease. Neurosurg Clin N Am 30, 137–146. - PubMed
    1. Diestro JDB, Vesagas TS, Teleg RA, Aguilar JA, Anlacan JP, Jamora RDG (2018) Deep brain stimulation for Parkinson disease in the Philippines: Outcomes of the Philippine Movement Disorder Surgery Center. World Neurosurg 115, e650–e658. - PubMed
    1. Gubellini P, Eusebio A, Oueslati A, Melon C, Kerkerian-Le Goff L, Salin P (2006) Chronic high-frequency stimulation of the subthalamic nucleus and L-DOPA treatment in experimental parkinsonism: Effects on motor behaviour and striatal glutamate transmission. Eur J Neurosci 24, 1802–1814. - PubMed
    1. Elble RJ, Shih L, Cozzens JW (2018) Surgical treatments for essential tremor. Expert Rev Neurother 18, 303–321. - PubMed
    1. Dallapiazza RF, Lee DJ, De Vloo P, Fomenko A, Hamani C, Hodaie M, Kalia SK, Fasano A, Lozano AM (2019) Outcomes from stereotactic surgery for essential tremor. J Neurol Neurosurg Psychiatry 90, 474–482. - PMC - PubMed

Publication types

Substances

LinkOut - more resources